thiophenes has been researched along with Angiogenesis, Pathologic in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (23.26) | 18.2507 |
2000's | 13 (30.23) | 29.6817 |
2010's | 17 (39.53) | 24.3611 |
2020's | 3 (6.98) | 2.80 |
Authors | Studies |
---|---|
Balamurali, MM; Das, B; Jagavelu, K; Janni, M; Kumari, R; Peruncheralathan, S; Rashid, M; Singh, H; Singh, S; Thirupathi, A; Wahajuddin, M | 1 |
Callan, E; Entringer, B; Joshi, A; Konduri, GG; Michalkiewicz, T; Parchur, AK; Rana, U; Teng, RJ | 1 |
Ademi, H; Chaachouay, H; Gassmann, M; Gerst, D; Gorr, TA; Shinde, DA; Vogel, J | 1 |
Amaro, A; Bachetti, T; Bianchi, G; Emionite, L; Pfeffer, U; Piaggio, F; Raffaghello, L; Ravera, S; Traverso, C | 1 |
Hou, MC; Hsieh, YC; Huang, CC; Huang, SF; Huang, YH; Lee, KC; Li, TH; Lin, HC; Liu, RS; Tsai, HC; Yang, YY | 1 |
Bostancıoğlu, RB; Demirel, S; Koparal, AT; Turgut Cin, G | 1 |
Altun, A; Kaya, TT; Turgut, NH | 1 |
Bao, X; Chen, J; Ding, X; Wang, C; Wang, W; Wang, Y; Zhang, F; Zhou, J | 1 |
Bharate, SB; Bhushan, S; Guru, SK; Joshi, P; Kumar, A; Mudududdla, R; Sharma, S; Vishwakarma, RA; Wani, A | 1 |
Allison, S; Hoang, KG; Murray, M; Petrovic, N | 1 |
Altun, A; Ataseven, H; Kaya, TT; Koyluoglu, G; Turgut, NH | 1 |
Machado, VA; Peixoto, D; Queiroz, MJ; Soares, R | 1 |
Bao, XF; Chen, GL; Chen, JL; Jiang, XR; Liu, X; Wang, LH; Wu, CF; Yang, JY | 1 |
Brooks, SC; Choi, JH; Kim, SG; Kim, YW; Lee, MO; Lee, WH | 1 |
Goldstein, MR; Mascitelli, L; Pezzetta, F | 1 |
Barr, S; Chou, J; Depeille, P; Epstein, DM; Falcon, BL; Fogarty, J; Gokhale, PC; McDonald, DM; Miglarese, M | 1 |
Bartelds, B; Berger, RMF; Boersma, B; Dickinson, MG; Mohaupt, S; Takens, J; van Albada, M; van Loon, RLE; Wijnberg, H | 1 |
Kang, SG; Kim, SG; Lee, WH; Lee, YH; Lee, YS | 1 |
Carew, JS; Espitia, CM; Esquivel, JA; Giles, FJ; Janssen, B; Lewis, JD; Mülbaier, M; Nawrocki, ST; Schultes, CM | 1 |
Altun, M; Anderson, KC; Carrasco, R; Chauhan, D; Fulcinniti, M; Hideshima, T; Kessler, BM; Kingsbury, WD; Kodrasov, MP; Kumar, KG; Leach, CA; McDermott, JL; Minvielle, S; Munshi, N; Nicholson, B; Orlowski, R; Richardson, P; Shah, PK; Tian, Z; Weinstock, J; Zhou, B | 1 |
Chen, QF; Li, D; Wang, HB; Wang, L; Wang, Y | 1 |
Collen, A; Grimbergen, J; Hanemaaijer, R; Koolwijk, P; Lupu, F; Peters, E; Quax, PH; van Hinsbergh, VW; van Lent, N | 1 |
Augustin, HG | 1 |
Buhr, HJ; Foitzik, T; Hines, OJ; Hotz, B; Hotz, HG; Reber, HA | 1 |
Bergers, G; Hanahan, D | 1 |
Buesa, JM; de Buitrago, GG; Gómez-Moutón, C; Jiménez-Baranda, S; Lacalle, RA; Mañes, S; Martínez-A, C; Mira, E | 1 |
Devy, L; Foidart, JM; Frankenne, F; Grams, F; Krell, HW; Maquoi, E; Noël, A; Olivier, F; Sounni, NE | 1 |
Bruns, CJ; Graeb, C; Guba, M; Heeschen, C; Ischenko, I; Jauch, KW; Joka, M; Papyan, A; Schmid, G; Schrepfer, S | 1 |
Godlewski, A; Meleń-Mucha, G; Mucha, SA; Stepień, H | 1 |
Gao, SJ; Qian, LW; Xie, J; Ye, F | 1 |
Belotti, D; Borsotti, P; Brown, PD; Drudis, T; Garofalo, A; Giavazzi, R; Scanziani, E; Taraboletti, G | 1 |
Copeland, J; Gilbertson-Beadling, S; Ledbetter, S; Mitchell, M; Petzold, G; Poorman, R; Powers, EA; Scott, PS; Stamp-Cole, M; Wallace, TL | 1 |
Brown, PD; Giavazzi, R | 1 |
Alonso, DF; Bal de Kier Joffé, E; Davel, L; Farías, EF; Ladeda, V; Puricelli, L | 1 |
Kuwano, M; Ono, M | 2 |
Dickson, RB; Hawkins, MJ; Wojtowicz-Praga, SM | 1 |
Bergers, G; Folkman, J; Hanahan, D; Javaherian, K; Lo, KM | 1 |
Bu, W; Li, XM; Qin, LX; Tang, ZY; Xia, JL | 1 |
Chambers, AF; Groom, AC; MacDonald, IC; Morris, VL; Schmidt, EE; Varghese, HJ; Wylie, S | 1 |
Balkwill, FR; Dias, S; Holdsworth, H; Scott, KA | 1 |
Duriez, M; Levy, BI; Mallat, Z; Silvestre, JS; Tamarat, R; Tedgui, A | 1 |
Angeles, T; Clapper, ML; Robinson, C; Ruggeri, BA; Wilkinson, J | 1 |
5 review(s) available for thiophenes and Angiogenesis, Pathologic
Article | Year |
---|---|
[Angiogenesis research--quo vadis?].
Topics: Adult; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Apoptosis; Bevacizumab; Cell Communication; Drug Evaluation, Preclinical; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Ephrins; Forecasting; Growth Substances; Humans; Hydroxamic Acids; Intercellular Signaling Peptides and Proteins; Lymphokines; Metalloendopeptidases; Mice; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Phenylalanine; Randomized Controlled Trials as Topic; Receptors, Vascular Endothelial Growth Factor; Research; Signal Transduction; Thalidomide; Thiophenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Matrix metalloproteinase inhibition: a review of anti-tumour activity.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Humans; Melanoma, Experimental; Metalloendopeptidases; Neovascularization, Pathologic; Phenylalanine; Protease Inhibitors; Thiophenes | 1995 |
[Development of anti tumor agents targeting angiogenesis].
Topics: Antineoplastic Agents; Clinical Trials as Topic; Cyclohexanes; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Hydroxamic Acids; Interferon-alpha; Interleukin-12; Neoplasms; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Phenylalanine; Platelet Factor 4; Polysaccharides, Bacterial; Sesquiterpenes; Thalidomide; Thiophenes; Triazines; Triazoles; Tumor Cells, Cultured | 1997 |
Matrix metalloproteinase inhibitors.
Topics: Antineoplastic Agents; Cell Division; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Down-Regulation; Drugs, Investigational; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Hydroxamic Acids; Metalloendopeptidases; Molecular Weight; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Phenylalanine; Protease Inhibitors; Protein Kinase C; Proteins; Thiophenes; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3; Tissue Inhibitor of Metalloproteinases | 1997 |
[Neovascularization and tumor development].
Topics: Angiostatins; Antibiotics, Antineoplastic; Antineoplastic Agents; Collagen; Cyclohexanes; Endostatins; Humans; Hydroxamic Acids; Interferons; Interleukin-12; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Peptide Fragments; Phenylalanine; Plasminogen; Sesquiterpenes; Thalidomide; Thiophenes | 1998 |
38 other study(ies) available for thiophenes and Angiogenesis, Pathologic
Article | Year |
---|---|
2,3-Difunctionalized Benzo[
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Breast Neoplasms; Cell Movement; Cell Proliferation; Female; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Phosphorylation; Thiophenes; Tumor Cells, Cultured; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2022 |
AMP-Kinase Dysfunction Alters Notch Ligands to Impair Angiogenesis in Neonatal Pulmonary Hypertension.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Animals, Newborn; Biphenyl Compounds; Ductus Arteriosus; Electron Transport; Endothelial Cells; Enzyme Activation; Female; Hypertension, Pulmonary; Intracellular Signaling Peptides and Proteins; Jagged-1 Protein; Ligands; Lung; Membrane Proteins; Metformin; Mitochondria; Neovascularization, Pathologic; Persistent Fetal Circulation Syndrome; Phosphorylation; Pregnancy; Protein Kinases; Pyrones; Receptors, Notch; Sheep; Thiophenes; Threonine; Transfection | 2020 |
Targeting neovascularization and respiration of tumor grafts grown on chick embryo chorioallantoic membranes.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Dogs; Humans; Mice; Monocarboxylic Acid Transporters; Neoplasm Proteins; Neoplasms, Experimental; Neovascularization, Pathologic; Oxygen Consumption; Pyrimidinones; Symporters; Thiophenes; Xenograft Model Antitumor Assays | 2021 |
Curcumin induces a fatal energetic impairment in tumor cells in vitro and in vivo by inhibiting ATP-synthase activity.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Curcumin; Energy Metabolism; Female; Hexokinase; I-kappa B Kinase; L-Lactate Dehydrogenase; Malondialdehyde; Mice; Mice, Nude; Mitochondrial Proton-Translocating ATPases; Neoplasms; Neovascularization, Pathologic; Oxygen Consumption; Phosphofructokinases; Pyruvate Kinase; Reactive Oxygen Species; Thiophenes | 2018 |
Beneficial Effects of the Peroxisome Proliferator-Activated Receptor α/γ Agonist Aleglitazar on Progressive Hepatic and Splanchnic Abnormalities in Cirrhotic Rats with Portal Hypertension.
Topics: Animals; Caco-2 Cells; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Male; Neovascularization, Pathologic; Oxazoles; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Thiophenes | 2018 |
Novel ferrocenyl-containing N-acetyl-2-pyrazolines inhibit in vitro angiogenesis and human lung cancer growth by interfering with F-actin stress fiber polimeryzation.
Topics: Actins; Angiogenesis Inhibitors; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Collagen; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Drug Combinations; Ferrous Compounds; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Laminin; Lung Neoplasms; Neovascularization, Pathologic; Polymerization; Proteoglycans; Pyrazoles; Tetrazolium Salts; Thiazoles; Thiophenes | 2013 |
Anticancer effect of COX-2 inhibitor DuP-697 alone and in combination with tyrosine kinase inhibitor (E7080) on colon cancer cell lines.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; HT29 Cells; Humans; Neovascularization, Pathologic; Phenylurea Compounds; Protein-Tyrosine Kinases; Quinolines; Thiophenes | 2014 |
Versatile reticular polyethylenimine derivative-mediated targeted drug and gene codelivery for tumor therapy.
Topics: Acrylates; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Delivery Systems; Enzyme-Linked Immunosorbent Assay; Humans; Imidazoles; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Atomic Force; Microvessels; Neovascularization, Pathologic; Polyethyleneimine; Thiophenes | 2014 |
3-(Benzo[d][1,3]dioxol-5-ylamino)-N-(4-fluorophenyl)thiophene-2-carboxamide overcomes cancer chemoresistance via inhibition of angiogenesis and P-glycoprotein efflux pump activity.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzodioxoles; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Neovascularization, Pathologic; Protein Conformation; Quinolines; Structure-Activity Relationship; Thiophenes; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2015 |
Prostanoids regulate angiogenesis acting primarily on IP and EP4 receptors.
Topics: Benzyl Compounds; Cell Movement; Dinoprostone; Endothelial Cells; Epoprostenol; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Neovascularization, Pathologic; Neovascularization, Physiologic; Prostaglandins I; Real-Time Polymerase Chain Reaction; Receptors, Epoprostenol; Receptors, G-Protein-Coupled; Receptors, Prostaglandin E, EP4 Subtype; Thiophenes; Triazoles; Xanthones | 2015 |
Effects of a Multikinase Inhibitor Motesanib (AMG 706) Alone and Combined with the Selective DuP-697 COX-2 Inhibitor on Colorectal Cancer Cells.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chickens; Chorioallantoic Membrane; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; HT29 Cells; Humans; Indoles; Neovascularization, Pathologic; Niacinamide; Oligonucleotides; Protein Kinase Inhibitors; Thiophenes | 2016 |
Antiangiogenic 1-Aryl-3-[3-(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas Inhibit MCF-7 and MDA-MB-231 Human Breast Cancer Cell Lines Through PI3K/Akt and MAPK/Erk Pathways.
Topics: Angiogenesis Inhibitors; Apoptosis; Blotting, Western; Breast; Breast Neoplasms; Cell Proliferation; Cells, Cultured; Female; Humans; MAP Kinase Signaling System; Neovascularization, Pathologic; Phenylurea Compounds; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Thiophenes; Urea | 2016 |
SYP-5, a novel HIF-1 inhibitor, suppresses tumor cells invasion and angiogenesis.
Topics: Antineoplastic Agents; Benzopyrans; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; MAP Kinase Signaling System; Microvessels; Neoplasm Invasiveness; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Prohibitins; Proto-Oncogene Proteins c-akt; Thiophenes; Vascular Endothelial Growth Factor A | 2016 |
Oltipraz and dithiolethione congeners inhibit hypoxia-inducible factor-1alpha activity through p70 ribosomal S6 kinase-1 inhibition and H2O2-scavenging effect.
Topics: Adenylate Kinase; Animals; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Free Radical Scavengers; Gene Expression Regulation, Neoplastic; Humans; Hydrogen Peroxide; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin; Mice; Neovascularization, Pathologic; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; Protein Stability; Pyrazines; Ribosomal Protein S6 Kinases, 70-kDa; Thiones; Thiophenes; Transcription, Genetic; Ubiquitin | 2009 |
Platelet inhibition and cancer promotion.
Topics: Animals; Endothelium, Vascular; Humans; Neoplasms; Neovascularization, Pathologic; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Spleen; Stem Cells; T-Lymphocytes, Regulatory; Thiophenes | 2010 |
Reduced VEGF production, angiogenesis, and vascular regrowth contribute to the antitumor properties of dual mTORC1/mTORC2 inhibitors.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Humans; Immunohistochemistry; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Nude; Microscopy, Confocal; Multiprotein Complexes; Neoplasms, Experimental; Neovascularization, Pathologic; Proteins; Quinolines; Sirolimus; Thiophenes; TOR Serine-Threonine Kinases; Transcription Factors; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2011 |
Mast cell inhibition improves pulmonary vascular remodeling in pulmonary hypertension.
Topics: Animals; Cell Proliferation; Chymases; Cromolyn Sodium; Disease Models, Animal; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Lung; Male; Mast Cells; Monocrotaline; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Rats; Rats, Wistar; Sulfonamides; Thiophenes | 2012 |
Hypoxia-inducible factor-1α inhibition by a pyrrolopyrazine metabolite of oltipraz as a consequence of microRNAs 199a-5p and 20a induction.
Topics: Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cobalt; HT29 Cells; Humans; Hydrogen Peroxide; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin; MicroRNAs; Neoplasm Invasiveness; Neovascularization, Pathologic; Pyrazines; Pyridazines; Pyrroles; Thiones; Thiophenes | 2012 |
ELR510444 inhibits tumor growth and angiogenesis by abrogating HIF activity and disrupting microtubules in renal cell carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Renal Cell; Cell Hypoxia; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Neoplasms; Mice; Microtubules; Mitosis; Neovascularization, Pathologic; Polymerization; Sulfonamides; Thiophenes; Tumor Burden; Vascular Endothelial Growth Factor A; Von Hippel-Lindau Tumor Suppressor Protein; Xenograft Model Antitumor Assays | 2012 |
A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Bortezomib; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Dexamethasone; Drug Resistance, Neoplasm; Drug Therapy, Combination; Humans; Lenalidomide; Mice; Mice, SCID; Molecular Sequence Data; Multiple Myeloma; Neovascularization, Pathologic; Protease Inhibitors; Proto-Oncogene Proteins c-mdm2; Pyrazines; Random Allocation; Thalidomide; Thiophenes; Ubiquitin Thiolesterase; Ubiquitin-Specific Peptidase 7; Xenograft Model Antitumor Assays | 2012 |
Mesothelin promotes invasion and metastasis in breast cancer cells.
Topics: Animals; Breast Neoplasms; Butadienes; Cell Line, Tumor; Cell Movement; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; Lymphatic Metastasis; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; MCF-7 Cells; Mesothelin; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Neovascularization, Pathologic; Nitriles; Phenylalanine; Protease Inhibitors; Thiophenes; Transplantation, Heterologous | 2012 |
Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix.
Topics: Adenoviridae; Aprotinin; Cells, Cultured; Collagen; Culture Media; Defective Viruses; Drug Synergism; Endothelial Growth Factors; Endothelium, Vascular; Fibrin; Fibroblast Growth Factor 2; Genetic Vectors; Heart Diseases; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Neovascularization, Pathologic; Neovascularization, Physiologic; Phenylalanine; Protease Inhibitors; Thiophenes; Thrombosis; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-3; Transduction, Genetic; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Evaluation of vascular endothelial growth factor blockade and matrix metalloproteinase inhibition as a combination therapy for experimental human pancreatic cancer.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Chi-Square Distribution; Disease Models, Animal; Drug Therapy, Combination; Endothelial Growth Factors; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Matrix Metalloproteinases; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Pancreatic Neoplasms; Phenylalanine; Probability; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric; Thiophenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Combining antiangiogenic agents with metronomic chemotherapy enhances efficacy against late-stage pancreatic islet carcinomas in mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Islet Cell; Chronotherapy; Indoles; Matrix Metalloproteinase Inhibitors; Mice; Neovascularization, Pathologic; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Thiophenes | 2002 |
Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Membrane; Dipeptides; Doxycycline; Enzyme Activation; Humans; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Membrane Microdomains; Membrane Proteins; Neovascularization, Pathologic; Phenylalanine; Protein Binding; Protein Transport; Receptors, LDL; Recombinant Fusion Proteins; Thiophenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2004 |
Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Aorta; Breast Neoplasms; Cell Line, Tumor; Disease Progression; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Humans; Inhibitory Concentration 50; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Microscopy, Fluorescence; Models, Chemical; Neoplasm Invasiveness; Neoplasm Transplantation; Neovascularization, Pathologic; Phenylalanine; Piperazines; Protease Inhibitors; Pyrimidines; Rats; Thiophenes; Time Factors; Up-Regulation | 2004 |
The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Lewis Lung; Cell Division; Cells, Cultured; Coculture Techniques; Collagen; Drug Combinations; Endothelium, Vascular; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Laminin; Mice; Mice, Inbred C57BL; Muscle, Smooth; Neoplasm Transplantation; Neovascularization, Pathologic; Neutralization Tests; Oxadiazoles; Propylene Glycols; Proteoglycans; Receptors, CXCR4; Receptors, Lysosphingolipid; Sphingosine; Thiophenes; Transcriptional Activation; Transplantation, Isogeneic; Umbilical Veins; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2007 |
Inhibition of estrogen-induced pituitary tumor growth and angiogenesis in Fischer 344 rats by the matrix metalloproteinase inhibitor batimastat.
Topics: Angiogenesis Inhibitors; Animals; Cell Proliferation; Diethylstilbestrol; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Estrogens; Image Processing, Computer-Assisted; Male; Metalloendopeptidases; Neovascularization, Pathologic; Organ Size; Phenylalanine; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactinoma; Proliferating Cell Nuclear Antigen; Protease Inhibitors; Rats; Rats, Inbred F344; Thiophenes | 2007 |
Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases.
Topics: Autocrine Communication; Cell Transformation, Viral; Cells, Cultured; Collagenases; Endothelial Cells; Gene Expression Regulation, Enzymologic; Herpesvirus 8, Human; Humans; Neoplasm Invasiveness; Neovascularization, Pathologic; Paracrine Communication; Phenylalanine; Protease Inhibitors; Response Elements; RNA, Messenger; RNA, Neoplasm; Sarcoma, Kaposi; Thiophenes; Transcription Factor AP-1; Umbilical Veins; Up-Regulation | 2007 |
Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases.
Topics: Animals; Dose-Response Relationship, Drug; Female; Hemangioendothelioma; Metalloendopeptidases; Mice; Neoplasm Invasiveness; Neovascularization, Pathologic; Phenylalanine; Thiophenes; Time Factors | 1995 |
The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism.
Topics: Animals; Aorta; Doxycycline; Gelatinases; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Minocycline; Neoplasm Proteins; Neovascularization, Pathologic; Phenylalanine; Rats; Rats, Inbred F344; Thiophenes | 1995 |
Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model.
Topics: Amidines; Amiloride; Animals; Antineoplastic Agents; Cell Division; Diuretics; Enzyme Inhibitors; Female; Fibrinolysis; Fibronectins; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Thiophenes; Triamterene; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1996 |
Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.
Topics: Angiostatins; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Carcinoma, Islet Cell; Collagen; Cyclohexanes; Disease Progression; Drug Evaluation, Preclinical; Endostatins; Female; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Staging; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Pancreatic Neoplasms; Peptide Fragments; Phenylalanine; Plasminogen; Sesquiterpenes; Thiophenes | 1999 |
Effect of antiangiogenic agents on experimental animal models of hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Cell Division; Cyclohexanes; Liver Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Metastasis; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Phenylalanine; Sesquiterpenes; Suramin; Thiophenes; Triazoles | 1999 |
The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells.
Topics: Animals; Cell Movement; Cell Survival; Injections, Intraperitoneal; Injections, Intravenous; Liver Neoplasms; Melanoma, Experimental; Mesenteric Veins; Mice; Microscopy, Video; Neovascularization, Pathologic; Phenylalanine; Thiophenes; Tumor Cells, Cultured | 1999 |
Exploiting changes in the tumour microenvironment with sequential cytokine and matrix metalloprotease inhibitor treatment in a murine breast cancer model.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Disease Models, Animal; Drug Administration Schedule; Drug Synergism; Female; Interleukin-12; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Phenylalanine; Protease Inhibitors; Thiophenes | 2000 |
Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis.
Topics: Angiography; Animals; Blood Flow Velocity; Capillaries; Disease Models, Animal; Endothelial Growth Factors; Enzyme Activation; Femoral Artery; Fibroblast Growth Factor 2; Hindlimb; Interleukin-10; Ischemia; Laser-Doppler Flowmetry; Lymphokines; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Phenylalanine; Platelet Endothelial Cell Adhesion Molecule-1; Protease Inhibitors; Thiophenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth.
Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Cell Division; Dose-Response Relationship, Drug; Endothelium, Vascular; Hemangiosarcoma; Humans; Insulin-Like Growth Factor I; Liver; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Pyrazines; Rats; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 4; Receptors, Fibroblast Growth Factor; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Ribonuclease, Pancreatic; Thiones; Thiophenes; Transplantation, Heterologous; Tumor Cells, Cultured | 2002 |